Loading…
Loading…
VBIX (Viewbix Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
VBIX does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for VBIX and 80,000+ other tickers.
See exactly how VBIX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VBIX and 80,000+ other tickers.
Viewbix Inc. operates as a digital advertising platform company in Israel. It operates in two divisions: Ad-Search and Digital Content. The Ad-Search division develops and markets various technological software solutions that automate, optimize, and monetize online campaigns by acquiring and routing internet user traffic to search engines. The Digital Content division creates, edits, and markets content in various languages to various target audiences to generate revenues from advertisements displayed together with the content, which are posted on digital content, marketing, and advertising…
Toronto, Ontario – May 27, 2026 - TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), is providing the following update with respect to its previously announced proposed acquisition (the " Transaction ") of approximately 54.01% of the issued and outstanding ordinary shares (the “ Purchased Shares ”) of CliniQuantum Ltd. (" CliniQuantum "), as initially announced by news release dated March 10, 2026. The Company is providing this news release to supplement the disclosure contained in its March 10, 2026 news release, including in respect of (i) the license agreement between CliniQuantum and Quantum X Labs Ltd., (ii) the basis for the consideration payable under the Transaction and the fairness opinion received by the Company's board of directors, (iii) certain amendments to the share purchase agreement dated March 9, 2026 (the “ SPA ”) between the Company, CliniQuantum and the holders of the Purchased Shares (the “ Selling Shareholders ”), including the establishment of a floor price for future share issuances, an extension of the outside date, and the execution of lock-up arrangements by the Selling Shareholders as a condition of closing.
Tel Aviv, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL) ("Quantum X" or the "Company"), an advanced technologies company (formerly known as Viewbix Inc. (Nasdaq: VBIX)), to commence trading today under new name and new Nasdaq symbol, following a comprehensive corporate rebranding.
Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) ("Viewbix" or the "Company"), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. ("Quantum X Labs"). The rebranding represents the Company's evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.
Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”). The rebranding represents the Company's evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.
Tel Aviv, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that Nuclear Quantum, a portfolio company of its wholly-owned subsidiary, Quantum X Labs Ltd. (“Quantum X Labs”), has achieved a strategic milestone.